![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Antiviral Activity of Tenofovir Alafenamide (TAF) against Major NRTI-Resistant Viruses:
Improvement over TDF/TFV is Driven by Higher TFV-DP Loading in Target cells
|
|
|
Reported by Jules Levin
International Workshop on HIV & Hepatitis
Virus Drug Resistance and Curative Strategies
June 4-8, 2013
Toronto, Canada
N Margot, Y Liu, D Babusis, MD Miller, C Callebaut
Gilead Sciences Inc, Foster City, CA, United States
![Res1.gif](../images/060913/060913-10/Res1.gif)
![Res2.gif](../images/060913/060913-10/Res2.gif)
![Res3.gif](../images/060913/060913-10/Res3.gif)
![Res4.gif](../images/060913/060913-10/Res4.gif)
![Res5.gif](../images/060913/060913-10/Res5.gif)
![Res6.gif](../images/060913/060913-10/Res6.gif)
![Res7.gif](../images/060913/060913-10/Res7.gif)
![Res8.gif](../images/060913/060913-10/Res8.gif)
![Res9.gif](../images/060913/060913-10/Res9.gif)
![Res10.gif](../images/060913/060913-10/Res10.gif)
![Res11.gif](../images/060913/060913-10/Res11.gif)
![Res12.gif](../images/060913/060913-10/Res12.gif)
![Res13.gif](../images/060913/060913-10/Res13.gif)
![Res14.gif](../images/060913/060913-10/Res14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|